# Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab

**Authors:** Nadine Abdallah, David Murray, Angela Dispenzieri, Prashant Kapoor, Morie A. Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Wilson Gonsalves, Eli Muchtar, Nelson Leung, David Dingli, Taxiarchis Kourelis, Rahma Warsame, Moritz Binder, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar

PMC · DOI: 10.1038/s41375-024-02308-5 · Leukemia · 2024-06-17

## Full-text entities

- **Chemicals:** daratumumab (MESH:C556306)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11286504/full.md

---
Source: https://tomesphere.com/paper/PMC11286504